TrialDiabetologia2019

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.

Zien Zhou et al.PubMed ↗Full text ↗Publisher ↗

A later paper about NCT01032629. The trial’s primary report, PMID 28605608, speaks for it on the map; the numbers here are shown and do not vote.

No numbers read from the abstract.